Reaffirmed: Sartorius (ETR:SRT) Hold Rating Maintained by equity analysts Joh. Berenberg Gossler & Co. KG; EUR 200.00 Target in Place

Share

Sartorius (ETR:SRT) Rating Reaffirmed

In a comprehensive report disseminated on Saturday, 5 December, The Hold rating of Sartorius (ETR:SRT) shares was reaffirmed by Analysts at Joh. Berenberg Gossler & Co. KG, who now has a EUR 200.00 TP on the stock. Joh. Berenberg Gossler & Co. KG’s TP suggests a possible downside of -13.98% from the closing share price of the company.

From a total of 2 analysts covering Sartorius (ETR:SRT) stock, 0 rate it a ”Buy”, 0 a “Sell”, and 2 a ”Hold”. This means that 0% of the ratings are positive. The highest target price is €5 while the lowest target price is €4.5. The mean of all analyst targets is €4.75 with a -29.26% below today’s (€254.45) stock price. Sartorius was the topic of 6 analyst reports since July 22, 2015 according to the firm StockzIntelligence Inc. HSBC upgraded shares on November 26 to “Buy” rating. Berenberg maintained SRT stock in a recent report from September 16 with “Hold” rating. Finally, Kepler Cheuvreux maintained the stock with “Hold” rating in a report issued on a July 22.

The stock increased 5.98% or EUR 14.35 on December 4, striking EUR 254.45. Approximately 1,055 shares of stock traded hands or 115.31% up from the average. Sartorius AG (ETR:SRT) has declined 57.09% since May 4, 2015 and is downtrending. It has underperformed by 54.31% the S&P500.

Reaffirmed: Sartorius (ETR:SRT) Hold Rating Maintained by equity analysts Joh. Berenberg Gossler & Co. KG; EUR 200.00 Target in Place

Sartorius AG is a Germany-based holding firm engaged in the provision of laboratory and process technologies, as well as equipment. The company has a market cap of 4.65 billion EUR. The Firm operates three business divisions: Bioprocess Solutions; Lab Products & Services, and Industrial Weighing. It has 45.2 P/E ratio. The Bioprocess Solutions segment provides integrated solutions for the pharmaceutical industry, including filtration systems, process control tools, purification equipment and fluid management, among others.

According to Zacks Investment Research, “StarTek, Inc. is a global provider of process management services and owns and operates branded vertical market Internet web sites. Their process management service platforms include E-commerce support and fulfillment, provisioning management for telecommunications systems, high-end inbound technical support, and an offering of supply chain management services. As an outsourcer of process management services as its core business, StarTek allows its clients to focus on their primary business, reduce overhead, replace fixed costs with variable costs, and reduce working capital needs.” Get a free copy of the Zacks research report on Sartorius AG (SRT).

COMMENTS: